Sort   by:  
 Page size 
Unknownp53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction.
Not available
S-EPMC7693367 | biostudies-literature
UnknownDetermination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid.
Not available
S-EPMC7352284 | biostudies-literature
UnknownCerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients.
Not available
S-EPMC7268320 | biostudies-literature
UnknownClinical applicability of miR517a detection in liquid biopsies of ETMR patients.
Not available
S-EPMC10175469 | biostudies-literature
UnknownTERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.
Not available
S-EPMC6231195 | biostudies-literature
UnknownA whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumors.
Not available
S-EPMC10237280 | biostudies-literature
UnknownCerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade Glioma.
Not available
S-EPMC7766483 | biostudies-literature
UnknownTERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF<sup>V600E</sup>/TERT promoter double-mutated glioma.
Not available
S-EPMC6685154 | biostudies-literature
UnknownAlternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.
Not available
S-EPMC11889718 | biostudies-literature
UnknownFibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness.
Not available
S-EPMC9052585 | biostudies-literature
Sort   by:  
 Page size